204 related articles for article (PubMed ID: 34898032)
21. The Fidelity of a Pharmacy-Based Oral HIV Pre-Exposure Prophylaxis Delivery Model in Kenya.
Omollo V; Asewe M; Mogere P; Maina G; Kuo AP; Odoyo J; Oware K; Baeten JM; Kohler P; Owens T; Bukusi EA; Ngure K; Ortblad KF
J Acquir Immune Defic Syndr; 2023 Aug; 93(5):379-386. PubMed ID: 37079900
[TBL] [Abstract][Full Text] [Related]
22. Key barriers and enablers associated with uptake and continuation of oral pre-exposure prophylaxis (PrEP) in the public sector in Zimbabwe: Qualitative perspectives of general population clients at high risk for HIV.
Gombe MM; Cakouros BE; Ncube G; Zwangobani N; Mareke P; Mkwamba A; Prescott MR; Bhatasara T; Murwira M; Mangwiro AZ; Prust ML
PLoS One; 2020; 15(1):e0227632. PubMed ID: 31931514
[TBL] [Abstract][Full Text] [Related]
23. Integrating PrEP into HIV care clinics could improve partner testing services and reinforce mutual support among couples: provider views from a PrEP implementation project in Kenya.
Odoyo JB; Morton JF; Ngure K; O'Malley G; Mugwanya KK; Irungu E; Awuor M; Dolla A; Ongolly F; Bukusi EA; Mugo NR; Baeten JM;
J Int AIDS Soc; 2019 Jul; 22 Suppl 3(Suppl Suppl 3):e25303. PubMed ID: 31321911
[TBL] [Abstract][Full Text] [Related]
24. "It went through the roof": an observation study exploring the rise in PrEP uptake among Zimbabwean female sex workers in response to adaptations during Covid-19.
Matambanadzo P; Busza J; Mafaune H; Chinyanganya L; Machingura F; Ncube G; Steen R; Phillips A; Cowan FM
J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25813. PubMed ID: 34713613
[TBL] [Abstract][Full Text] [Related]
25. Pre-exposure prophylaxis uptake and early continuation among pregnant and post-partum women within maternal and child health clinics in Kenya: results from an implementation programme.
Kinuthia J; Pintye J; Abuna F; Mugwanya KK; Lagat H; Onyango D; Begnel E; Dettinger J; Baeten JM; John-Stewart G;
Lancet HIV; 2020 Jan; 7(1):e38-e48. PubMed ID: 31813837
[TBL] [Abstract][Full Text] [Related]
26. Brief Report: Integration of PrEP Services Into Routine Antenatal and Postnatal Care: Experiences From an Implementation Program in Western Kenya.
Pintye J; Kinuthia J; Roberts DA; Wagner AD; Mugwanya K; Abuna F; Lagat H; Owiti G; Levin CE; Barnabas RV; Baeten JM; John-Stewart G
J Acquir Immune Defic Syndr; 2018 Dec; 79(5):590-595. PubMed ID: 30204720
[TBL] [Abstract][Full Text] [Related]
27. Design of a care pathway for pharmacy-based PrEP delivery in Kenya: results from a collaborative stakeholder consultation.
Ortblad KF; Mogere P; Roche S; Kamolloh K; Odoyo J; Irungu E; Mugo NR; Pintye J; Baeten JM; Bukusi E; Ngure K;
BMC Health Serv Res; 2020 Nov; 20(1):1034. PubMed ID: 33176785
[TBL] [Abstract][Full Text] [Related]
28. A community-based dynamic choice model for HIV prevention improves PrEP and PEP coverage in rural Uganda and Kenya: a cluster randomized trial.
Kakande ER; Ayieko J; Sunday H; Biira E; Nyabuti M; Agengo G; Kabami J; Aoko C; Atuhaire HN; Sang N; Owaranganise A; Litunya J; Mugoma EW; Chamie G; Peng J; Schrom J; Bacon MC; Kamya MR; Havlir DV; Petersen ML; Balzer LB;
J Int AIDS Soc; 2023 Dec; 26(12):e26195. PubMed ID: 38054535
[TBL] [Abstract][Full Text] [Related]
29. Estimating the costs and perceived benefits of oral pre-exposure prophylaxis (PrEP) delivery in ten counties of Kenya: a costing and a contingent valuation study.
Forsythe S; Kioko U; Mahiane G; Glaubius R; Musau A; Gichangi A; Reed J; Were D
Front Reprod Health; 2024; 6():1278764. PubMed ID: 38463424
[TBL] [Abstract][Full Text] [Related]
30. HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: a randomized trial in Kenya.
Ortblad KF; Kearney JE; Mugwanya K; Irungu EM; Haberer JE; Barnabas RV; Donnell D; Mugo NR; Baeten JM; Ngure K
Trials; 2019 Jul; 20(1):396. PubMed ID: 31272495
[TBL] [Abstract][Full Text] [Related]
31. Integrating PrEP delivery in public health family planning clinics: a protocol for a pragmatic stepped wedge cluster randomized trial in Kenya.
Mugwanya KK; Matemo D; Scoville CW; Beima-Sofie KM; Meisner A; Onyango D; Mugambi M; Feutz E; Grabow C; Barnabas R; Weiner B; Baeten JM; Kinuthia J;
Implement Sci Commun; 2021 Dec; 2(1):135. PubMed ID: 34895357
[TBL] [Abstract][Full Text] [Related]
32. Two-Way Short Message Service (SMS) Communication May Increase Pre-Exposure Prophylaxis Continuation and Adherence Among Pregnant and Postpartum Women in Kenya.
Pintye J; Rogers Z; Kinuthia J; Mugwanya KK; Abuna F; Lagat H; Sila J; Kemunto V; Baeten JM; John-Stewart G; Unger JA
Glob Health Sci Pract; 2020 Mar; 8(1):55-67. PubMed ID: 32139420
[TBL] [Abstract][Full Text] [Related]
33. Public Health Implications of Adapting HIV Pre-exposure Prophylaxis Programs for Virtual Service Delivery in the Context of the COVID-19 Pandemic: Systematic Review.
Patel P; Kerzner M; Reed JB; Sullivan PS; El-Sadr WM
JMIR Public Health Surveill; 2022 Jun; 8(6):e37479. PubMed ID: 35486813
[TBL] [Abstract][Full Text] [Related]
34. Standardised patient encounters to improve quality of counselling for pre-exposure prophylaxis (PrEP) in adolescent girls and young women (AGYW) in Kenya: study protocol of a cluster randomised controlled trial.
Larsen A; Wilson KS; Kinuthia J; John-Stewart G; Richardson BA; Pintye J; Abuna F; Lagat H; Owens T; Kohler P
BMJ Open; 2020 Jun; 10(6):e035689. PubMed ID: 32565464
[TBL] [Abstract][Full Text] [Related]
35. The effectiveness, feasibility and acceptability of HIV service delivery at private pharmacies in sub-Saharan Africa: a scoping review.
Kuo AP; Roche SD; Mugambi ML; Pintye J; Baeten JM; Bukusi E; Ngure K; Stergachis A; Ortblad KF
J Int AIDS Soc; 2022 Oct; 25(10):e26027. PubMed ID: 36285619
[TBL] [Abstract][Full Text] [Related]
36. Caring for the whole person: transgender-competent HIV pre-exposure prophylaxis as part of integrated primary healthcare services in Vietnam.
Doan AH; Vu CMH; Nguyen TT; Green KE; Phan HTT; Janamnuaysook R; Vu BN; Le TM; Do KQ; Tran TT; Ngo TM; Basu L; Tran LK; Humeau Z
J Int AIDS Soc; 2022 Oct; 25 Suppl 5(Suppl 5):e25996. PubMed ID: 36225133
[TBL] [Abstract][Full Text] [Related]
37. Barriers to and strategies for early implementation of pharmacy-delivered HIV PrEP services in Kenya: An analysis of routine data.
Nakambale HN; Roche SD; Mogere P; Omollo V; Kuo AP; Stergachis A; Baeten JM; Bukusi E; Ngure K; Mugambi ML; Ortblad KF
Front Reprod Health; 2023; 5():1023568. PubMed ID: 36895656
[TBL] [Abstract][Full Text] [Related]
38. Using a HIV prevention cascade for identifying missed opportunities in PrEP delivery in Kenya: results from a programmatic surveillance study.
Were D; Musau A; Mutegi J; Ongwen P; Manguro G; Kamau M; Marwa T; Gwaro H; Mukui I; Plotkin M; Reed J
J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25537. PubMed ID: 32602658
[TBL] [Abstract][Full Text] [Related]
39. Efficiency of 6-month PrEP dispensing with HIV self-testing in Kenya: an open-label, randomised, non-inferiority, implementation trial.
Ngure K; Ortblad KF; Mogere P; Bardon AR; Thomas KK; Mangale D; Kiptinness C; Gakuo S; Mbaire S; Nyokabi J; Mugo NR; Baeten JM
Lancet HIV; 2022 Jul; 9(7):e464-e473. PubMed ID: 35777410
[TBL] [Abstract][Full Text] [Related]
40. Selecting implementation strategies to improve implementation of integrated PrEP for pregnant and postpartum populations in Kenya: a sequential explanatory mixed methods analysis.
Hicks S; Odhiambo B; Abuna F; Dettinger JC; Ngumbau N; Gómez L; Sila J; Oketch G; Sifuna E; Weiner BJ; John-Stewart G; Kinuthia J; Wagner AD
Implement Sci Commun; 2023 Aug; 4(1):93. PubMed ID: 37580795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
